BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 19578113)

  • 21. A case of refractory chronic neutrophilic pustular folliculitis treated with adalimumab.
    Sand FL; Thomsen SF
    Dermatol Ther; 2015; 28(2):86-8. PubMed ID: 25546110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amicrobial pustulosis and systemic lupus erythematosus: a case].
    Saiag P; Blanc F; Marinho E; De la Blanchardière A; Leconte I; Cocheton JJ; Tulliez M
    Ann Dermatol Venereol; 1993; 120(11):779-81. PubMed ID: 8210111
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biological treatment of rare inflammatory rheumatic diseases].
    Baslund B
    Ugeskr Laeger; 2008 Jun; 170(24):2150-2. PubMed ID: 18565301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab treatment in pachydermoperiostosis: a rare disease without an effective therapeutic option.
    da Costa FV; de Magalhães Souza Fialho SC; Zimmermann AF; Neves FS; Werner de Castro GR; Pereira IA
    J Clin Rheumatol; 2010 Jun; 16(4):183-4. PubMed ID: 20414127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bullous systemic erythematosus. A case report.
    Aboobaker J; Ramsaroop R; Abramowitz I; Naran AD
    S Afr Med J; 1986 Jan; 69(1):49-51. PubMed ID: 3510460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcorneal pustular dermatosis: 50 years on.
    Cheng S; Edmonds E; Ben-Gashir M; Yu RC
    Clin Exp Dermatol; 2008 May; 33(3):229-33. PubMed ID: 18355359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bullous systemic lupus erythematosus].
    Bacman D; Ostendorf B; Megahed M; Ruzicka T; Schneider M; Kuhn A
    Hautarzt; 2004 Apr; 55(4):392-5. PubMed ID: 15021938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Amicrobial pustulosis and systemic lupus erythematosus].
    Oberlin P; Bagot M; Perrussel M; Leteinturier F; Wechsler J; Revuz J
    Ann Dermatol Venereol; 1991; 118(11):824-5. PubMed ID: 1789646
    [No Abstract]   [Full Text] [Related]  

  • 29. TNF inhibition in SLE: where do we stand?
    Aringer M; Smolen JS
    Lupus; 2009 Jan; 18(1):5-8. PubMed ID: 19074162
    [No Abstract]   [Full Text] [Related]  

  • 30. Bullous systemic lupus erythematosus successfully treated with rituximab.
    Lowe CD; Brahe CA; Green B; Lam TK; Meyerle JH
    Cutis; 2019 Jun; 103(6):E5-E7. PubMed ID: 31348461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vesiculobullous rash in a patient with systemic lupus erythematosus.
    Landor M; Rosenstreich DL
    Ann Allergy; 1993 Mar; 70(3):196-203. PubMed ID: 8452312
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.
    Jalili A; Kinaciyan T; Barisani T; Peck-Radosavljevic M; Stingl G; Geusau A; Wöhrl S
    Iran J Immunol; 2009 Mar; 6(1):55-8. PubMed ID: 19293479
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pustulosis of Sneddon Wilkinson disease and multiple myeloma].
    Villasante De La Puente A; Hormaechea Beldarrain JA; García Aguinaga ML; Vera López E; Gilsanz Fernández C
    An Med Interna; 2001 Jul; 18(7):373-5. PubMed ID: 11534423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained remission after infliximab in a child with vasculitis refractory to conventional immunosuppressives including interferon-alpha.
    Evereklioglu C; Borlu M
    Br J Ophthalmol; 2008 Aug; 92(8):1034, 1148-9. PubMed ID: 18653594
    [No Abstract]   [Full Text] [Related]  

  • 35. Infliximab in serpiginous choroiditis.
    Seve P; Mennesson E; Grange JD; Broussolle C; Kodjikian L
    Acta Ophthalmol; 2010 Dec; 88(8):e342-3. PubMed ID: 19799587
    [No Abstract]   [Full Text] [Related]  

  • 36. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) in a patient with multiple sclerosis.
    Köhler LD; Möhrenschlager M; Worret WI; Ring J
    Dermatology; 1999; 199(1):69-70. PubMed ID: 10449965
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful treatment of mucous membrane pemphigoid with infliximab.
    Heffernan MP; Bentley DD
    Arch Dermatol; 2006 Oct; 142(10):1268-70. PubMed ID: 17043180
    [No Abstract]   [Full Text] [Related]  

  • 38. What is the association between the tumor necrosis factor-alpha inhibitor infliximab and complex regional pain syndrome type I?
    Paraskevas KI
    Paediatr Anaesth; 2008 Jul; 18(7):689-90. PubMed ID: 18331547
    [No Abstract]   [Full Text] [Related]  

  • 39. Pure motor spastic quadriparesis in systemic lupus erythematosus.
    Saigal R; Kumar R; Venugopal ; Vottery R
    J Assoc Physicians India; 1999 Feb; 47(2):238-9. PubMed ID: 10999100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of systemic lupus erythematosus in a patient with rheumatoid arthritis following treatment conversion of infliximab to adalimumab.
    Havel J; Aboutalebi S; Doughty L; Wirges M
    J Drugs Dermatol; 2008 Aug; 7(8):796-8. PubMed ID: 18720701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.